- Agency 100
- Partner Content
Pharma and med-tech execs discuss key insights from MM+M’s 2022 Healthcare Marketers Survey that inform how marketing will look in a post-pandemic era.
In March at MM+M’s first in-person #TrendTalks event in three years, a group of seasoned pharma marketers and other industry experts gathered for an insightful series of roundtables, led by MM+M’s editor-at-large Marc Iskowitz, on what marketing will look like in a post-COVID era.
Largely driven by key data points garnered from MM+M’s latest Healthcare Marketers Survey, the discussions tackled some intriguing questions such as:
• Where is the industry in using web-based analytics to understand HCP needs and to personalize their experiences?
• To what extent are biopharma and med-tech companies leveraging first-party data gathering to target ads to consumers?
• How can marketing and market access teams — which are traditionally siloed — partner on digital solutions to improve the patient experience?
Participants also dove into the prevailing trends that have dictated changes in the industry marketing playbook including the global pandemic, racial disparities in healthcare and the privacy-safe strategies being driven by Facebook, Apple and Google.
Read on for some of the incredible insights and takeaways shared by the group.
Offered Free by: MM+M
See All Resources from: MM+M
This download should complete shortly. If the resource doesn't automatically download, please, click here.